Abstract
Head and neck tumors (HNT) are among the most common types of cancer worldwide, with an estimated 300.000 annual deaths. Distinct classes of risk factors (e.g. tobacco and alcohol abuse versus Human Papilomavirus (HPV) persistent infection) are associated with different tumor subsets that share molecular and pathological characteristics. However, lack of specific therapies renders a poor …